In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti

In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

Published:2017-05-10 Issue:389 Volume:9 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Arlauckas Sean P.¹²³^ORCID,Garris Christopher S.¹⁴^ORCID,Kohler Rainer H.¹^ORCID,Kitaoka Maya⁵,Cuccarese Michael F.¹^ORCID,Yang Katherine S.¹^ORCID,Miller Miles A.¹²^ORCID,Carlson Jonathan C.¹,Freeman Gordon J.⁶^ORCID,Anthony Robert M.⁵,Weissleder Ralph¹²³^ORCID,Pittet Mikael J.¹²^ORCID

Affiliation:

1. Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, MA 02114, USA.

2. Department of Radiology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, MA 02114, USA.

3. Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.

4. Graduate Program in Immunology, Harvard Medical School, Boston, MA 02115, USA.

5. Center for Immunology and Infectious Disease, Massachusetts General Hospital, 149 8th Street, Charlestown, MA 02129, USA.

6. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Abstract

Tumor-associated macrophages limit anti–PD-1 effects by removing the antibody from CD8 + T cells.

Funder

National Institutes of Health

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference52 articles.

1. Enhancement of Antitumor Immunity by CTLA-4 Blockade

2. The blockade of immune checkpoints in cancer immunotherapy

3. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

4. Combination cancer immunotherapy and new immunomodulatory targets

5. The Three Es of Cancer Immunoediting

Cited by 499 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to immunotherapy;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Challenges in validation of combination treatment strategies for CRC using patient-derived organoids;Journal of Experimental & Clinical Cancer Research;2024-09-11

3. Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer;Cancers;2024-09-04

4. Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation;EJNMMI Research;2024-08-28

5. Exploring the role of the immune microenvironment in hepatocellular carcinoma: Implications for immunotherapy and drug resistance;eLife;2024-08-15